Intriguingly, French patients with COVID-19 analyzed in this study were exclusively exposed to SARS-CoV-2 expressing spike G614 variant, suggesting that the mutation does not reduce the antigenicity against spike but instead reduces IgG, IgM, and IgA binding. This evidence concerns the gene CD40LG and COVID-19.